Free Trial

GoodRx (GDRX) Competitors

GoodRx logo
$4.57 +0.15 (+3.39%)
As of 01/17/2025 04:00 PM Eastern

GDRX vs. QXO, ETSY, MARA, LYFT, TNET, FTDR, CARG, CLVT, ALIT, and DXC

Should you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include QXO (QXO), Etsy (ETSY), MARA (MARA), Lyft (LYFT), TriNet Group (TNET), Frontdoor (FTDR), CarGurus (CARG), Clarivate (CLVT), Alight (ALIT), and DXC Technology (DXC). These companies are all part of the "business services" industry.

GoodRx vs.

GoodRx (NASDAQ:GDRX) and QXO (NASDAQ:QXO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.

GoodRx has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, QXO has a beta of 2.32, suggesting that its stock price is 132% more volatile than the S&P 500.

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 58.7% of QXO shares are owned by institutional investors. 4.2% of GoodRx shares are owned by insiders. Comparatively, 51.3% of QXO shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

GoodRx presently has a consensus price target of $8.38, suggesting a potential upside of 83.26%. Given GoodRx's stronger consensus rating and higher probable upside, analysts plainly believe GoodRx is more favorable than QXO.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.73
QXO
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

QXO has a net margin of 30.08% compared to GoodRx's net margin of -2.05%. GoodRx's return on equity of 5.35% beat QXO's return on equity.

Company Net Margins Return on Equity Return on Assets
GoodRx-2.05% 5.35% 2.51%
QXO 30.08%1.58%1.30%

In the previous week, QXO had 4 more articles in the media than GoodRx. MarketBeat recorded 12 mentions for QXO and 8 mentions for GoodRx. GoodRx's average media sentiment score of 0.57 beat QXO's score of 0.33 indicating that GoodRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GoodRx
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
QXO
4 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

QXO has lower revenue, but higher earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than QXO, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoodRx$750.27M2.32-$8.87M-$0.03-152.33
QXO$54.52M105.25-$1.07M-$9.12-1.54

GoodRx received 72 more outperform votes than QXO when rated by MarketBeat users.

CompanyUnderperformOutperform
GoodRxOutperform Votes
72
39.56%
Underperform Votes
110
60.44%
QXON/AN/A

Summary

GoodRx beats QXO on 11 of the 18 factors compared between the two stocks.

Get GoodRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GDRX vs. The Competition

MetricGoodRxData processing & preparation IndustryMedical SectorNASDAQ Exchange
Market Cap$1.74B$4.38B$5.21B$9.14B
Dividend YieldN/A3.00%5.13%4.02%
P/E Ratio-152.3333.9489.3417.36
Price / Sales2.327.241,240.0477.11
Price / Cash11.0230.5543.7535.97
Price / Book2.376.125.314.79
Net Income-$8.87M$44.77M$122.54M$225.00M
7 Day Performance8.29%3.97%0.59%2.62%
1 Month Performance2.93%3.11%2.55%3.81%
1 Year Performance-28.93%19.24%25.29%20.10%

GoodRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GDRX
GoodRx
4.2317 of 5 stars
$4.57
+3.4%
$8.38
+83.3%
-28.9%$1.74B$750.27M-152.33950Short Interest ↓
QXO
QXO
1.298 of 5 stars
$15.42
-1.5%
N/AN/A$6.31B$56.84M-1.69195Gap Up
ETSY
Etsy
4.4966 of 5 stars
$53.34
+1.5%
$62.54
+17.3%
-24.8%$6.00B$2.80B27.212,420Short Interest ↓
MARA
MARA
3.6343 of 5 stars
$16.72
-6.4%
$25.80
+54.3%
+23.4%$5.38B$598.75M21.169Options Volume
Gap Up
LYFT
Lyft
4.7832 of 5 stars
$12.91
-0.5%
$17.78
+37.7%
+6.0%$5.36B$5.46B-80.692,945
TNET
TriNet Group
4.2407 of 5 stars
$91.32
+1.7%
$117.00
+28.1%
-22.2%$4.53B$4.97B17.603,600
FTDR
Frontdoor
3.5902 of 5 stars
$55.22
-0.5%
$49.50
-10.4%
+75.6%$4.19B$1.83B18.282,080Short Interest ↓
Analyst Revision
News Coverage
Positive News
CARG
CarGurus
3.5819 of 5 stars
$35.44
-0.3%
$37.86
+6.8%
+61.9%$3.68B$888.97M-77.041,200
CLVT
Clarivate
3.4728 of 5 stars
$5.01
-1.2%
$7.10
+41.7%
-44.7%$3.56B$2.58B-2.5212,000Short Interest ↓
ALIT
Alight
3.3839 of 5 stars
$6.55
+0.2%
$10.61
+62.0%
-19.9%$3.56B$3.36B-13.6516,000
DXC
DXC Technology
2.3919 of 5 stars
$19.32
-0.8%
$20.89
+8.1%
-10.8%$3.50B$13.26B241.53130,000

Related Companies and Tools


This page (NASDAQ:GDRX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners